Sarah A. Frise, PhD

Executive Director Safety Epidemiology and Risk Management
AstraZeneca, Canada

Poster(s):

• (A-201) An evidence base to support the establishment of a fit-for-purpose quality management system for secondary data pharmacoepidemiological studies
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET